European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

EAU presents at the CAU annual meeting: understanding the side-effects of ADT

International cooperation between various urological associations was high on the agenda of the 17th Annual Meeting of the Chinese Urological Association.

Fri, 15 Oct 2010
Chinese Urological AssociationADT

October 2010- International cooperation between various urological associations was high on the agenda of the 17th Annual Meeting of the Chinese Urological Association. The meeting takes place on 14-17 October 2010 in Xi’an, China and is attended by more than 3000 urologists from various regions of this country.

The plenary session opened with a speech of Prof. Per-Anders Abrahamsson, EAU Secretary General, who said that scientific ties between China and Europe are growing stronger and that in the future more close cooperation will be fostered by both sides. In his lecture “Update on androgen deprivation therapy 2010”, he discussed the benefits and the challenges of this treatment modality both in terms of its universal application and regarding some of its China-related aspects.

Abrahamsson mentioned that this year much of the scientific discussion has been related to the development and testing of various new agents. He also mentioned that there are many concerns about the efficacy of intracellular testosterone suppression and better selection of indications for ADT. He then continued to discuss in details a topic, which, according to him has recently received much exposure in the field of scientific and practical urology – a better understanding of ADT side-effects. This increasingly improving understanding enables urologists to limit and control the rather severe morbidity of the therapy, such as an increased risk of cardio-vascular death, serious bone loss.

He mentioned that the management of ADT side-effects is directly related to the choice of treatment modality and timing, risk stratification, prevention and life-style intervention. With regard to the latter, Abrahamsson mentioned that various precautionary measures should be strongly advised to the patient – including retaining from smoking which, he said, is a serious problem among the Chinese men. Among other precautions on which the patient should be thoroughly educated by the urologist – a regular physical exercise, the so-called cerebral training, diet, cardio-vascular evaluation, the monitoring of glycemia and serum lipids as well as the use of cholesterol-lowering agents.

Abrahamsson went on to discuss the update in the field of intermittent androgen deprivation therapy, stating that currently evidence from clinical trials is poor. He mentioned that there is only one III-phase mature study so far and that there are no studies which thoroughly investigate the quality of life.

“In IAD there are more questions than answers today,” he concluded, “We still need to determine how to select the patients better, when to stop and resume the therapy and what kind of therapy is suited for what kind of patient.”

“It is also important to consider the means of selection of good prognostic patients,” he added, stating that the IAD is still considered today as an experimental approach, which is also indicated in the EAU Guidelines.

Share this article

Suggested for you

See all
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer